All posts tagged in reports emerged that the company was considering spinning off its Chinese business and listing shares in Hong Kong or Shanghai

In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy